Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA

Li Tu,1 Zhuo-Yu Wu,2 Xiu-Lin Yang,3 Qian Zhang,3 Ran Gu,3 Qian Wang,2 Tian Tian,2 Huan Yao,3 Xiang Qu,3 Jin-Yong Tian2,3 1Department of General Medical, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China; 2Department of Neurology, Guizhou Provincial People’s Hos...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tu L, Wu ZY, Yang XL, Zhang Q, Gu R, Wang Q, Tian T, Yao H, Qu X, Tian JY
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/4d30d80ffbb64bac8d1060deee8d497d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4d30d80ffbb64bac8d1060deee8d497d
record_format dspace
spelling oai:doaj.org-article:4d30d80ffbb64bac8d1060deee8d497d2021-12-02T08:49:40ZNeuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA1178-2021https://doaj.org/article/4d30d80ffbb64bac8d1060deee8d497d2020-01-01T00:00:00Zhttps://www.dovepress.com/neuroprotective-effect-and-mechanism-of-baicalin-on-parkinsons-disease-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Li Tu,1 Zhuo-Yu Wu,2 Xiu-Lin Yang,3 Qian Zhang,3 Ran Gu,3 Qian Wang,2 Tian Tian,2 Huan Yao,3 Xiang Qu,3 Jin-Yong Tian2,3 1Department of General Medical, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China; 2Department of Neurology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, China; 3Department of Emergency, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, ChinaCorrespondence: Jin-Yong TianDepartment of Emergency, Guizhou Provincial People’s Hospital, 83 Zhongshan East Road, Guiyang 550002, Guizhou, ChinaTel +86 851 8593 7194Email tianjinygpph@aliyun.comObjective: This research was aimed to investigate the effects of baicalin on 6-hydroxydopamine (6-OHDA)-induced rat model of Parkinson’s disease (PD) and the main mechanism of baicalin based on metabolomics.Methods: The rat model of PD was induced by 6-OHDA. The protective effects of baicalin on rat model of PD were evaluated by open field test and rotarod test. The anti-PD efficacy of baicalin was evaluated by examining the morphologic changes of neurons and the level of monoamine neurotransmitters in the striatum, the number and morphology of tyrosine hydroxylase (TH)-positive neurons, and oxidative stress. Combined with metabolomics methods, the pharmacodynamic mechanism of baicalin on PD pathogenesis was also explored.Results: Baicalin treatment improved the rod time and voluntary movement in rat model of PD (P<0.05) by the open field test and rotarod test. In addition, baicalin also protected from oxidative stress injury (P<0.05), and regulated the content of monoamine neurotransmitters dopamine, 3,4-dihydroxyphenylacetic acid, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid (P<0.05) and the number and morphology of TH-positive cells in 6-OHDA-induced PD model rats. By metabolomics, multivariate statistical analysis, and receiver operating characteristic curve analysis, we found that two metabolites N-acetyl aspartic acid and glutamic acid had a good diagnostic value. Quantitative analysis of metabolites showed a regulatory function of baicalin.Conclusion: Baicalin has significant protective effect on 6-OHDA-induced PD rats, which may play a protective role through an antioxidant, promoting the release of neurotransmitters and regulating the metabolism of N-acetyl aspartate and glutamate.Keywords: Parkinson’s disease, neurotransmitter, baicalin, metabolomicsTu LWu ZYYang XLZhang QGu RWang QTian TYao HQu XTian JYDove Medical Pressarticleparkinson diseaseneurotransmitterbaicalinmetabolomicsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 15, Pp 3615-3625 (2020)
institution DOAJ
collection DOAJ
language EN
topic parkinson disease
neurotransmitter
baicalin
metabolomics
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle parkinson disease
neurotransmitter
baicalin
metabolomics
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Tu L
Wu ZY
Yang XL
Zhang Q
Gu R
Wang Q
Tian T
Yao H
Qu X
Tian JY
Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
description Li Tu,1 Zhuo-Yu Wu,2 Xiu-Lin Yang,3 Qian Zhang,3 Ran Gu,3 Qian Wang,2 Tian Tian,2 Huan Yao,3 Xiang Qu,3 Jin-Yong Tian2,3 1Department of General Medical, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China; 2Department of Neurology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, China; 3Department of Emergency, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, ChinaCorrespondence: Jin-Yong TianDepartment of Emergency, Guizhou Provincial People’s Hospital, 83 Zhongshan East Road, Guiyang 550002, Guizhou, ChinaTel +86 851 8593 7194Email tianjinygpph@aliyun.comObjective: This research was aimed to investigate the effects of baicalin on 6-hydroxydopamine (6-OHDA)-induced rat model of Parkinson’s disease (PD) and the main mechanism of baicalin based on metabolomics.Methods: The rat model of PD was induced by 6-OHDA. The protective effects of baicalin on rat model of PD were evaluated by open field test and rotarod test. The anti-PD efficacy of baicalin was evaluated by examining the morphologic changes of neurons and the level of monoamine neurotransmitters in the striatum, the number and morphology of tyrosine hydroxylase (TH)-positive neurons, and oxidative stress. Combined with metabolomics methods, the pharmacodynamic mechanism of baicalin on PD pathogenesis was also explored.Results: Baicalin treatment improved the rod time and voluntary movement in rat model of PD (P<0.05) by the open field test and rotarod test. In addition, baicalin also protected from oxidative stress injury (P<0.05), and regulated the content of monoamine neurotransmitters dopamine, 3,4-dihydroxyphenylacetic acid, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid (P<0.05) and the number and morphology of TH-positive cells in 6-OHDA-induced PD model rats. By metabolomics, multivariate statistical analysis, and receiver operating characteristic curve analysis, we found that two metabolites N-acetyl aspartic acid and glutamic acid had a good diagnostic value. Quantitative analysis of metabolites showed a regulatory function of baicalin.Conclusion: Baicalin has significant protective effect on 6-OHDA-induced PD rats, which may play a protective role through an antioxidant, promoting the release of neurotransmitters and regulating the metabolism of N-acetyl aspartate and glutamate.Keywords: Parkinson’s disease, neurotransmitter, baicalin, metabolomics
format article
author Tu L
Wu ZY
Yang XL
Zhang Q
Gu R
Wang Q
Tian T
Yao H
Qu X
Tian JY
author_facet Tu L
Wu ZY
Yang XL
Zhang Q
Gu R
Wang Q
Tian T
Yao H
Qu X
Tian JY
author_sort Tu L
title Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
title_short Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
title_full Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
title_fullStr Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
title_full_unstemmed Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
title_sort neuroprotective effect and mechanism of baicalin on parkinson’s disease model induced by 6-ohda
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/4d30d80ffbb64bac8d1060deee8d497d
work_keys_str_mv AT tul neuroprotectiveeffectandmechanismofbaicalinonparkinsonrsquosdiseasemodelinducedby6ohda
AT wuzy neuroprotectiveeffectandmechanismofbaicalinonparkinsonrsquosdiseasemodelinducedby6ohda
AT yangxl neuroprotectiveeffectandmechanismofbaicalinonparkinsonrsquosdiseasemodelinducedby6ohda
AT zhangq neuroprotectiveeffectandmechanismofbaicalinonparkinsonrsquosdiseasemodelinducedby6ohda
AT gur neuroprotectiveeffectandmechanismofbaicalinonparkinsonrsquosdiseasemodelinducedby6ohda
AT wangq neuroprotectiveeffectandmechanismofbaicalinonparkinsonrsquosdiseasemodelinducedby6ohda
AT tiant neuroprotectiveeffectandmechanismofbaicalinonparkinsonrsquosdiseasemodelinducedby6ohda
AT yaoh neuroprotectiveeffectandmechanismofbaicalinonparkinsonrsquosdiseasemodelinducedby6ohda
AT qux neuroprotectiveeffectandmechanismofbaicalinonparkinsonrsquosdiseasemodelinducedby6ohda
AT tianjy neuroprotectiveeffectandmechanismofbaicalinonparkinsonrsquosdiseasemodelinducedby6ohda
_version_ 1718398360023465984